Among various types of immune checkpoints, two receptor classes are actively expressed on activated T cells, CTLA-4 and PD-1, which are targeted by cancer cells to negatively regulate the T cells’ function from killing the tumors [63]. This evidence concerns the gene PDCD1 and cancer.